SANA - Sana Biotechnology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SANA is currently covered by 3 analysts with an average price target of $7.58. This is a potential upside of $5.58 (279%) from yesterday's end of day stock price of $2.

Sana Biotechnology's activity chart (see below) currently has 0 price targets and 17 ratings on display. The stock rating distribution of SANA is 17.65% HOLD and 82.35% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 29.8 days.

Highest price target for SANA is $11, Lowest price target is $5, average price target is $8.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 23-Apr-2025. First documented stock forecast 01-Mar-2021.

Best performing analysts who are covering SANA - Sana Biotechnology:

Reni Benjamin Cory Kasimov Salveen Richter Matthew Harrison Emily Bodnar

Currently out of the existing stock ratings of SANA, 3 are a HOLD (17.65%), 14 are a BUY (82.35%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$9.18 (504.40%)

$11

19 days ago
(23-Apr-2025)

0/10 (0%)

$9.23 (521.47%)

Hold

$5

$3.18 (174.73%)

1 months 25 days ago
(17-Mar-2025)

2/4 (50%)

$2.72 (119.30%)

141

Buy

$13

$9.84 (311.39%)

2 years 3 months 18 days ago
(24-Jan-2023)

0/2 (0%)

$8.29 (176.01%)

Hold

$6

$2.84 (89.87%)

$34

2 years 6 months 9 days ago
(03-Nov-2022)

1/3 (33.33%)

$1 (20.00%)

8

Hold

$31

$25.76 (491.60%)

$35

3 years 9 months 8 days ago
(05-Aug-2021)

0/2 (0%)

$6.67 (32.51%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SANA (Sana Biotechnology) average time for price targets to be met?

On average it took 29.8 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on SANA (Sana Biotechnology) with a proven track record?

RENI BENJAMIN

Which analyst has the current lower performing score on SANA (Sana Biotechnology) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on SANA (Sana Biotechnology)?

Reni Benjamin works at JMP and has 2 price targets and 5 ratings on SANA

Which analyst is the currently most bullish on SANA (Sana Biotechnology)?

Cory Kasimov with highest potential upside - $25.76

Which analyst is the currently most reserved on SANA (Sana Biotechnology)?

Salveen Richter with lowest potential downside - $2.84

Sana Biotechnology in the News

SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or “the Company”) (NASDAQ: SANA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for...

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ: SANA) and certain officers.  The class action, filed in the United States District Court for the Western District of Washington, and docketed under 25-cv-00512, is on behalf...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?